Abstract

Within the pancreatic β-cells, insulin secretory granules (SGs) exist in functionally distinct pools, displaying variations in motility as well as docking and fusion capability. Current therapies that increase insulin secretion do not consider the existence of these distinct SG pools. Accordingly, these approaches are effective only for a short period, with a worsening of glycemia associated with continued decline in β-cell function. Insulin granule age is underappreciated as a determinant for why an insulin granule is selected for secretion and may explain why newly synthesized insulin is preferentially secreted from β-cells. Here, using a novel fluorescent timer protein, we aimed to investigate the preferential secretion model of insulin secretion and identify how granule aging is affected by variation in the β-cell environment, such as hyperglycemia. We demonstrate the use of a fluorescent timer construct, syncollin-dsRedE5TIMER, which changes its fluorescence from green to red over 18 h, in both microscopy and fluorescence-assisted organelle-sorting techniques. We confirm that the SG-targeting construct localizes to insulin granules in β-cells and does not interfere with normal insulin SG behavior. We visualize insulin SG aging behavior in MIN6 and INS1 β-cell lines and in primary C57BL/6J mouse and nondiabetic human islet cells. Finally, we separated young and old insulin SGs, revealing that preferential secretion of younger granules occurs in glucose-stimulated insulin secretion. We also show that SG population age is modulated by the β-cell environment in vivo in the db/db mouse islets and ex vivo in C57BL/6J islets exposed to different glucose environments.

Highlights

  • Within the pancreatic ␤-cells, insulin secretory granules (SGs) exist in functionally distinct pools, displaying variations in motility as well as docking and fusion capability

  • Insulin SGs exist in distinctly behaving pools, some of which exhibit higher motility [14, 39] or enhanced membrane-docking properties [8] and others that are more prone to fusion with the plasma membrane [40, 41] or appear to be preferentially degraded [14, 42]

  • By exploiting syncollin-dsRedE5TIMER’s ability to traffic as an insulin SG cargo protein, we demonstrate that granule preference can occur in SGs as young as 24 h old

Read more

Summary

Introduction

Within the pancreatic ␤-cells, insulin secretory granules (SGs) exist in functionally distinct pools, displaying variations in motility as well as docking and fusion capability. Under conditions of metabolic stress, ␤-cells could potentially lose their ability to distinguish young SGs from old; in diabetes, ␤-cells hypersecrete insulin to compensate for insulin resistance and eventually become degranulated [25,26,27]. Whether these changes are intrinsic to the SG or regulated by the ␤-cell environment is not defined

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call